285 related articles for article (PubMed ID: 15354258)
1. [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].
Hribaschek A; Pross M; Ridwelski K; Meyer F; Fenske A; Krüger S; Lippert H
Zentralbl Chir; 2004 Aug; 129(4):328-34. PubMed ID: 15354258
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of peritoneal carcinomatosis in experimental investigations with CPT-11 and oxaliplatin.
Hribaschek A; Pross M; Kuhn R; Krüger S; Ridwelski K; Halangk W; Boltze C; Lippert H
Anticancer Drugs; 2002 Jul; 13(6):605-14. PubMed ID: 12172506
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model.
Hribaschek A; Kuhn R; Pross M; Meyer F; Fahlke J; Ridwelski K; Boltze C; Lippert H
Surg Today; 2006; 36(1):57-62. PubMed ID: 16378195
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of peritoneal carcinomatosis in experimental investigations.
Hribaschek A; Kuhn R; Pross M; Lippert H; Halangk W; Boltze C; Ridwelski K
Int J Colorectal Dis; 2001 Sep; 16(5):340-5. PubMed ID: 11686534
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.
Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H
Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689
[TBL] [Abstract][Full Text] [Related]
6. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model.
Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H
Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H
Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000
[TBL] [Abstract][Full Text] [Related]
10. [Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].
Chauffert B; Dimanche-Boitrel MT; Genne P; Petit JM; Onier N; Jeannin JF
Gastroenterol Clin Biol; 1992; 16(3):215-9. PubMed ID: 1582536
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis.
Ridwelski K; Meyer F; Hribaschek A; Kasper U; Lippert H
J Surg Oncol; 2002 Jan; 79(1):10-6. PubMed ID: 11754372
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
[TBL] [Abstract][Full Text] [Related]
13. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients.
Elias D; Goere D; Blot F; Billard V; Pocard M; Kohneh-Shahri N; Raynard B
Ann Surg Oncol; 2007 Jun; 14(6):1818-24. PubMed ID: 17356950
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.
Leung V; Huo YR; Liauw W; Morris DL
Eur J Surg Oncol; 2017 Jan; 43(1):144-149. PubMed ID: 27780675
[TBL] [Abstract][Full Text] [Related]
15. [The update on pancreatic cancer chemotherapy].
Brasiūniene B; Juozaityte E; Brasiūnas V; Inciūra A
Medicina (Kaunas); 2003; 39(10):1016-25. PubMed ID: 14578647
[TBL] [Abstract][Full Text] [Related]
16. The European contribution to "Sugarbaker's protocol" for the treatment of colorectal peritoneal carcinomatosis.
Gómez Portilla A; Cendoya I; Olabarría I; Martínez de Lecea C; Gómez Martínez de Lecea C; Gil A; Martín E; Muriel J; Magrach L; Romero E; Lirola A; Guede N; Moraza N; Fernández E; Kvadatze M; Valdovinos M; Larrabide I; Ruiz de Alegría N; Fernández JL; Castillo C; Rua O; Ulibarrena MA
Rev Esp Enferm Dig; 2009 Feb; 101(2):97-102, 103-6. PubMed ID: 19335045
[TBL] [Abstract][Full Text] [Related]
17. Weekly oxaliplatin, high-dose folinic acid and 24h-5-fluorouracil (FUFOX) as salvage therapy in metastatic colorectal cancer patients pretreated with irinotecan and folinic acid/5-fluorouracil regimens.
Moehler M; Hoffmann T; Hildner K; Siebler J; Galle PR; Heike M
Z Gastroenterol; 2002 Dec; 40(12):957-64. PubMed ID: 12564419
[TBL] [Abstract][Full Text] [Related]
18. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
Gilly FN; Beaujard A; Glehen O; Grandclement E; Caillot JL; Francois Y; Sadeghi-Looyeh B; Gueugniaud PY; Garbit F; Benoit M; Bienvenu J; Vignal J
Anticancer Res; 1999; 19(3B):2317-21. PubMed ID: 10472351
[TBL] [Abstract][Full Text] [Related]
19. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
[TBL] [Abstract][Full Text] [Related]
20. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.
Elias D; Blot F; El Otmany A; Antoun S; Lasser P; Boige V; Rougier P; Ducreux M
Cancer; 2001 Jul; 92(1):71-6. PubMed ID: 11443611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
